SpyGlass Pharma, Inc. (SGP)

Last Closing Price: 32.24 (2026-11-16)

EBIT (Quarterly)

EBIT: Income before interest and taxes.

SpyGlass Pharma, Inc. (SGP) had EBIT of $-26.25M for the most recently reported fiscal quarter, ending 2026-09-30.

Figures for fiscal quarter ending 2026-09-30
Income Statement Financials
--
$-24.25M
--
--
$26.25M
$-26.25M
$1.99M
$-24.25M
$-24.25M
$-24.25M
$-24.25M
$-24.25M
$-24.25M
EBIT
$-26.25M
$-25.96M
33.45M
33.45M
$-0.73
$-0.73
Balance Sheet Financials
$217.91M
$6.34M
$8.43M
$226.35M
$14.30M
--
$1.61M
$15.91M
$210.44M
$210.44M
$210.44M
33.46M
Cash Flow Statement Financials
$-44.40M
$-1.06M
$157.79M
$96.36M
$208.69M
$112.33M
$6.07M
--
--
Fundamental Metrics & Ratios
15.24
--
--
--
--
--
--
--
--
--
--
$-49.47M
--
--
--
--
--
--
--
-11.52%
-11.52%
-10.71%
-11.52%
$6.29
$-1.48
$-1.33